Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
Perampanel is a novel antiepileptic drug, which antagonises AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) glutamate receptor. We describe perampanel as an adjunctive treatment for FIRES (febrile infection-related epilepsy syndrome) and other drug-resistant epilepsies. A single-cent...
Enregistré dans:
Auteurs principaux: | Guo Yong Lim BSc(Pharm.)(Hons.), Chun Liang Chen PharmD, BCPPS, Derrick Chan Wei Shih MCI |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fbd11a58dee249bcbf5074a81317f09a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of COVID on pediatrics. “AEP’s pandemic term”
par: Maria José Mellado
Publié: (2021) -
Pediatric eosinophilic esophagitis: a review for the clinician
par: Simona Barni, et autres
Publié: (2021) -
Weight Change for Pediatric Completers in a National Weight Loss Program
par: Rochelle Cason-Wilkerson MD, MPH, et autres
Publié: (2021) -
Simulation during COVID-19 pandemic in the Spanish pediatric intensive care units: New challenges in medical education
par: Laura Butragueño Laiseca, et autres
Publié: (2021) -
Utility of the Infantile Hemangioma Referral Score (IHReS) as a decision-making tool for referral to treatment
par: Leelawadee Techasatian, et autres
Publié: (2021)